{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T18:34:33Z","timestamp":1767897273692,"version":"3.49.0"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.phrs.2016.11.037","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T22:15:11Z","timestamp":1480716911000},"page":"53-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Should blood pressure goal be individualized in hypertensive patients?"],"prefix":"10.1016","volume":"118","author":[{"given":"Alexandra","family":"Yannoutsos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania","family":"Kheder-Elfekih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Halimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel E.","family":"Safar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Blacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.11.037_bib0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/jhh.2009.34","article-title":"Residual cardiovascular risk in treated hypertension and hyperlipidaemia: the PRIME Study","volume":"24","author":"Blacher","year":"2010","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.phrs.2016.11.037_bib0010","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2016.11.037_bib0015","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"25","author":"2007 Guidelines for the Management of Arterial Hypertension","year":"2007","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2016.11.037_bib0020","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.11.037_bib0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.2010.884","article-title":"Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease","volume":"304","author":"Cooper-DeHoff","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2016.11.037_bib0030","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/jama.2011.1650","article-title":"PRO FESS Investigators: level of systolic blood pressure within the normal range and risk of recurrent stroke","volume":"306","author":"Ovbiagele","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2016.11.037_bib0035","doi-asserted-by":"crossref","first-page":"884","DOI":"10.7326\/0003-4819-144-12-200606200-00005","article-title":"Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous","volume":"144","author":"Messerli","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.phrs.2016.11.037_bib0040","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1161\/HYPERTENSIONAHA.112.201400","article-title":"MORGAM Project Impact of age on the importance of systolic and diastolic blood pressures for stroke risk: the MOnica, Risk, Genetics, Archiving, and Monograph (MORGAM) Project","volume":"60","author":"Vishram","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2016.11.037_bib0045","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2016.11.037_bib0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/HYPERTENSIONAHA.113.01922","article-title":"Aggressive blood pressure lowering is dangerous: the J-curve: pro side of the arguement","volume":"63","author":"Mancia","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2016.11.037_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/fcp.12044","article-title":"French Society of Hypertension: Management of hypertension in adults: the 2013 French Society of Hypertension guidelines","volume":"28","author":"Blacher","year":"2014","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2016.11.037_bib0060","doi-asserted-by":"crossref","first-page":"d4891","DOI":"10.1136\/bmj.d4891","article-title":"Management of hypertension: summary of NICE guidance","volume":"343","author":"Krause","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2016.11.037_bib0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000000065","article-title":"Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension","volume":"32","author":"Weber","year":"2014","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2016.11.037_bib0070","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Study Group","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet."},{"key":"10.1016\/j.phrs.2016.11.037_bib0075","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1097\/01.hjh.0000194120.42722.ac","article-title":"FEVER Study Group. The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients","volume":"23","author":"Liu","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2016.11.037_bib0080","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1097\/HJH.0000000000000379","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels-overview and meta-analyses of randomized trials","volume":"32","author":"Thomopoulos","year":"2014","journal-title":"J. Hypertens."},{"issue":"311","key":"10.1016\/j.phrs.2016.11.037_bib0085","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"2014","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2016.11.037_bib0090","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1291\/hypres.31.2115","article-title":"Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS)","volume":"31","author":"JATOS Study Group","year":"2008","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.phrs.2016.11.037_bib0095","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/HYPERTENSIONAHA.109.146035","article-title":"Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study","volume":"56","author":"Ogihara","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2016.11.037_bib0100","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr039","article-title":"Is a systolic blood pressure target<140mmHg indicated in all hypertensives: subgroup analyses of findings from the randomized FEVER trial","volume":"32","author":"Zhang","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2016.11.037_bib0105","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/HYPERTENSIONAHA.115.06857","article-title":"Evidence to maintain the systolic blood pressure treatment threshold at 140 mmHg for stroke prevention: The Northern Manhattan Study","volume":"67","author":"Dong","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2016.11.037_bib0110","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis","volume":"387","author":"Xie","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2016.11.037_bib0115","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-Pressure control","volume":"373","author":"Research Group","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.11.037_bib0120","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/HJH.0000000000000881","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels \u2013 updated overview and meta-analyses of randomized trials","volume":"34","author":"Thomopoulos","year":"2016","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2016.11.037_bib0125","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/HYPERTENSIONAHA.109.141879","article-title":"Measurement of blood pressure in the office: recognizing the problem and proposing the solution","volume":"55","author":"Myers","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2016.11.037_bib0130","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"issue":"February","key":"10.1016\/j.phrs.2016.11.037_bib0135","article-title":"From epidemiological transition to modern cardiovascular epidemiology: hypertension in the 21 st century","author":"Blacher","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2016.11.037_bib0140","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1016\/j.ijcard.2013.03.021","article-title":"Prognosis in the hospitalized very elderly: the PROTEGER study","volume":"168","author":"Zhang","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2016.11.037_bib0145","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.11.037_bib0150","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1474-4422(08)70143-1","article-title":"Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial","volume":"7","author":"Peters","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.phrs.2016.11.037_bib0155","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/00004872-200404000-00029","article-title":"Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial","volume":"22","author":"Staessen","year":"2004","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2016.11.037_bib0160","doi-asserted-by":"crossref","first-page":"d7541","DOI":"10.1136\/bmj.d7541","article-title":"Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomized controlled trial","volume":"344","author":"Beckett","year":"2011","journal-title":"BMJ"},{"issue":"May","key":"10.1016\/j.phrs.2016.11.037_bib0165","article-title":"Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged #xps1 #75 years: a randomized clinical trial","author":"Williamson","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2016.11.037_bib0170","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1161\/01.CIR.96.1.308","article-title":"Hemodynamic patterns of age-related changes in blood pressure: the Framingham Heart Study","volume":"96","author":"Franklin","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.11.037_bib0175","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ancard.2014.05.013","article-title":"Orthostatic hypotension is associated with more severe hypertension in elderly autonomous diabetic patients from the French Gerodiab study at inclusion","volume":"63","author":"Bouhanick","year":"2014","journal-title":"Ann. Cardiol. Angeiol. (Paris)"},{"key":"10.1016\/j.phrs.2016.11.037_bib0180","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ypmed.2016.01.007","article-title":"Orthostatic hypotension and the risk of incidental cardiovascular diseases: a meta-analysis of prospective cohort studies","volume":"85","author":"Xin","year":"2016","journal-title":"Prev. Med."},{"key":"10.1016\/j.phrs.2016.11.037_bib0185","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/HJH.0b013e32832b1145","article-title":"The consensus statement on the definition of orthostatic hypotension: a revisit after 13 years","volume":"27","author":"Wieling","year":"2009","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2016.11.037_bib0190","doi-asserted-by":"crossref","first-page":"h949","DOI":"10.1136\/bmj.h949","article-title":"Drug-disease and drug\u2013drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines","volume":"350","author":"Dumbreck","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2016.11.037_bib0195","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1001\/jamainternmed.2015.5110","article-title":"Rates of deintensification of blood pressure and glycemic medication treatment based on levels of control and life expectancy in older patients with diabetes mellitus","volume":"175","author":"Sussman","year":"2015","journal-title":"JAMA Int. Med."},{"issue":"May (5)","key":"10.1016\/j.phrs.2016.11.037_bib0200","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/gerona\/glv228","article-title":"SPRINT study research group. characterizing frailty status in the systolic blood pressure intervention trial","volume":"71","author":"Pajewski","year":"2016","journal-title":"J. Gerontol. A. Biol. Sci. Med. Sci."},{"key":"10.1016\/j.phrs.2016.11.037_bib0205","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/1471-2261-14-193","article-title":"SEMI Working Group. Unanswered clinical questions in the management of cardiometabolic risk in the elderly: a statement of the Spanish Society of Internal Medicine","volume":"14","author":"G\u00f3mez-Huelgas","year":"2014","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.phrs.2016.11.037_bib0210","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1097\/00004872-200211000-00001","article-title":"Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials","volume":"20","author":"Zanchetti","year":"2002","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2016.11.037_bib0215","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bmj.321.7258.412","article-title":"Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study","volume":"321","author":"Adler","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2016.11.037_bib0220","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomized controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2016.11.037_bib0225","first-page":"CD008277","article-title":"Blood pressure targets for hypertension in people with diabetes mellitus","volume":"10","author":"Arguedas","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2016.11.037_bib0230","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1524-6175.2002.02045.x","article-title":"Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"4","author":"Cushman","year":"2002","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"10.1016\/j.phrs.2016.11.037_bib0235","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2337\/dc08-0435","article-title":"IDMPS investigators: multifaceted determinants for achieving glycemic control: the international diabetes management practice study (IDMPS)","volume":"32","author":"Chan","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2016.11.037_bib0240","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.11.037_bib0245","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.2337\/dc12-0650","article-title":"Individualizing targets and tactics for high-risk patients with type 2 diabetes: practical lessons from ACCORD and other cardiovascular trials","volume":"35","author":"Riddle","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2016.11.037_bib0250","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.2337\/dc13-2334","article-title":"Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial","volume":"37","author":"Margolis","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2016.11.037_bib0255","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/HJH.0000000000000898","article-title":"Hemodynamic parameters in hypertensive diabetic patients","volume":"34","author":"Yannoutsos","year":"2016","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2016.11.037_bib0260","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.11.037_bib0265","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/CIRCULATIONAHA.110.016337","article-title":"Blood pressure targets in subjects with type 2 diabetes mellitus\/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials","volume":"123","author":"Bangalore","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.11.037_bib0270","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.CIR.76.6.1183","article-title":"Measurements of coronary flow reserve: defining pathophysiology versus making decisions about patient care","volume":"76","author":"Klocke","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.11.037_bib0275","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/01.CIR.83.3.845","article-title":"Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle","volume":"83","author":"Polese","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.11.037_bib0280","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(79)91274-1","article-title":"Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension","volume":"1","author":"Stewart","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2016.11.037_bib0285","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(87)90231-5","article-title":"Benefits and potential harm of lowering high blood pressure","volume":"1","author":"Cruickshank","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2016.11.037_bib0290","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/bmj.303.6799.385","article-title":"Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study","volume":"303","author":"D'Agostino","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2016.11.037_bib0295","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1007856014581","article-title":"Antihypertensive treatment and the J-curve","volume":"14","author":"Cruickshank","year":"2000","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.phrs.2016.11.037_bib0300","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.jacc.2015.02.038","article-title":"Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension","volume":"65","author":"Rosendorff","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2016.11.037_bib0305","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/08037051.2015.1106750","article-title":"No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: the VALUE trial","volume":"25","author":"Kjeldsen","year":"2016","journal-title":"Blood Press."},{"key":"10.1016\/j.phrs.2016.11.037_bib0310","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/aje\/kwm145","article-title":"Biases in the identification of risk factor thresholds and J-curves","volume":"166","author":"Marschner","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.phrs.2016.11.037_bib0315","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/jhh.2009.36","article-title":"on behalf of the ESCAPP investigators: aortic pulse pressure and atherosclerotic structural alterations of coronary arteries","volume":"24","author":"Mourad","year":"2010","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.phrs.2016.11.037_bib0320","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.amjcard.2003.12.011","article-title":"Relation between pulse pressure and survival in patients with decompensated heart failure","volume":"93","author":"Aronson","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phrs.2016.11.037_bib0325","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1681\/ASN.V122218","article-title":"Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study","volume":"12","author":"Ruilope","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2016.11.037_bib0330","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/01.hjh.0000226212.34055.86","article-title":"Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial","volume":"24","author":"Arima","year":"2006","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2016.11.037_bib0335","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ana.22496","article-title":"Does achieving an intensive versus usual blood pressure level prevent stroke","volume":"71","author":"Lee","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2016.11.037_bib0340","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/jamainternmed.2014.8164","article-title":"Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs","volume":"175","author":"Mossello","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.phrs.2016.11.037_bib0345","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","article-title":"Progression of chronic kidney disease: the role of blood pressure control, proteinuria and angiotensin-converting enzyme inhibition: a patient-level meta-analysis","volume":"139","author":"Jafar","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.phrs.2016.11.037_bib0350","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJMoa0910975","article-title":"Intensive blood-pressure control in hypertensive chronic kidney disease","volume":"363","author":"Appel","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.11.037_bib0355","doi-asserted-by":"crossref","first-page":"754","DOI":"10.7326\/0003-4819-123-10-199511150-00003","article-title":"Blood pressure control, proteinuria, and the progression of renal disease: the Modification of Diet in Renal Disease Study","volume":"123","author":"Peterson","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.phrs.2016.11.037_bib0360","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/archinte.163.13.1555","article-title":"Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study","volume":"163","author":"Bakris","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.phrs.2016.11.037_bib0365","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1681\/ASN.2004110919","article-title":"Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations","volume":"16","author":"Pohl","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2016.11.037_bib0370","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/ndt\/gft321","volume":"29","author":"Verbeke","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.phrs.2016.11.037_bib0375","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jacc.2013.09.063","article-title":"Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects","volume":"63","author":"Ben-Shlomo","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2016.11.037_bib0380","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3109\/07420528.2010.510230","article-title":"Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study","volume":"27","author":"Hermida","year":"2010","journal-title":"Chronobiol. Int."},{"key":"10.1016\/j.phrs.2016.11.037_bib0385","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/CIRCULATIONAHA.108.797936","article-title":"Single versus combined blood pressure components and risk for cardiovascular disease: the Framingham Heart Study","volume":"119","author":"Franklin","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.11.037_bib0390","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.diabet.2009.04.010","article-title":"Pulse pressure strongly predicts cardiovascular disease risk in patients with type 2 diabetes from the Swedish National Diabetes Register (NDR)","volume":"35","author":"Nilsson","year":"2009","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.phrs.2016.11.037_bib0395","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1161\/hy0202.098325","article-title":"Central pulse pressure and mortality in end-stage renal disease","volume":"39","author":"Safar","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2016.11.037_bib0400","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1161\/HYPERTENSIONAHA.107.090068","article-title":"Central blood pressure measurements and antihypertensive therapy: a consensus document","volume":"50","author":"Agabiti-Rosei","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2016.11.037_bib0405","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/hrt.2005.067934","article-title":"Relation between aortic stiffness and coronary flow reserve in patients with coronary artery disease","volume":"92","author":"Fukuda","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.phrs.2016.11.037_bib0410","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1093\/brain\/awr253","article-title":"Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene\/Environment Susceptibility \u2013 Reykjavik Study","volume":"134","author":"Mitchell","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2016.11.037_bib0415","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/HYPERTENSIONAHA.111.177469","article-title":"Ito S. Central pulse pressure and aortic stiffness determine renal hemodynamics: pathophysiological implication for microalbuminuria in hypertension","volume":"58","author":"Hashimoto","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2016.11.037_bib0420","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1152\/japplphysiol.90549.2008","article-title":"Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage","volume":"105","author":"Mitchell","year":"2008","journal-title":"J. Appl. Physiol. (1985)"},{"key":"10.1016\/j.phrs.2016.11.037_bib0425","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/hc1002.105135","article-title":"Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-Year period","volume":"105","author":"Benetos","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.11.037_bib0430","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1046\/j.1523-1755.2003.00932.x","article-title":"Aortic pulse wave velocity index and mortality in end-stage renal disease","volume":"63","author":"Blacher","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2016.11.037_bib0435","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.atherosclerosis.2015.05.007","volume":"241","author":"Vlachopoulos","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2016.11.037_bib0440","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2016.11.037_bib0445","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.11.037_bib0450","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahl\u00f6f","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2016.11.037_bib0455","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","volume":"366","author":"Dahl\u00f6f","year":"2005","journal-title":"Lancet"},{"issue":"January","key":"10.1016\/j.phrs.2016.11.037_bib0460","article-title":"Angiotensin system blockade combined with calcium channel blockers is superior to other combinations in cardiovascular protection with similar blood pressure reduction: a meta-analysis in 20,451 hypertensive patients","author":"Chi","year":"2016","journal-title":"J. Clin. Hypertens (Greenwich"},{"key":"10.1016\/j.phrs.2016.11.037_bib0465","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1161\/HYPERTENSIONAHA.114.05582","article-title":"Left ventricular wall stress-mass-heart rate product and cardiovascular events in treated hypertensive patients: LIFE study","volume":"66","author":"Devereux","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2016.11.037_bib0470","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jacc.2003.07.039","article-title":"Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril\/indapamide in hypertensive subjects: comparison with atenolol","volume":"43","author":"London","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2016.11.037_bib0475","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1161\/CIRCULATIONAHA.105.595496","article-title":"Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study","volume":"113","author":"Williams","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.11.037_bib0480","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1056\/NEJMra060433","article-title":"Ambulatory blood-pressure monitoring","volume":"354","author":"Pickering","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.11.037_bib0485","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/HYPERTENSIONAHA.107.100727","article-title":"Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension","volume":"51","author":"Fagard","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2016.11.037_bib0490","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/07420528.2012.701127","article-title":"Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level\u2013the normotensive non-dipper paradox","volume":"30","author":"Hermida","year":"2013","journal-title":"Chronobiol. Int."},{"key":"10.1016\/j.phrs.2016.11.037_bib0495","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/j.1532-5415.2008.01946.x","article-title":"Orthostatic hypotension and risk of cardiovascular disease in elderly people: the Rotterdam study","volume":"56","author":"Verwoert","year":"2008","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.phrs.2016.11.037_bib0500","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/HJH.0b013e3283350e8c","article-title":"Consequences of orthostatic blood pressure variability in middle-aged men (The Malm\u00f6 Preventive Project)","volume":"28","author":"Fedorowski","year":"2010","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2016.11.037_bib0505","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ajh.2010.146","article-title":"Morbidity and mortality of orthostatic hypotension: implications for management of cardiovascular disease","volume":"24","author":"Benvenuto","year":"2011","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.phrs.2016.11.037_bib0510","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.116.303641","article-title":"Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal","volume":"116","author":"Zanchetti","year":"2015","journal-title":"Circ. Res."},{"issue":"Suppl. 2","key":"10.1016\/j.phrs.2016.11.037_bib0515","doi-asserted-by":"crossref","first-page":"S234","DOI":"10.2337\/dcS15-3027","article-title":"What should Be the target blood pressure in elderly patients with diabetes?","volume":"39","author":"Solini","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2016.11.037_bib0520","doi-asserted-by":"crossref","first-page":"e5567","DOI":"10.1136\/bmj.e5567","article-title":"Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study","volume":"345","author":"Vamos","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2016.11.037_bib0525","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1161\/01.CIR.103.9.1245","article-title":"Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study","volume":"103","author":"Franklin","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.11.037_bib0530","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jacc.2015.10.084","article-title":"Pulse pressure and risk for cardiovascular events in patients with atherothrombosis: from the REACH registry","volume":"67","author":"Selvaraj","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2016.11.037_bib0535","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1161\/HYPERTENSIONAHA.114.04581","article-title":"Does low diastolic blood pressure contribute to the risk of recurrent hypertensive cardiovascular disease events? The Framingham Heart Study","volume":"65","author":"Franklin","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2016.11.037_bib0540","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/01.HYP.0000165020.14745.79","article-title":"Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome","volume":"45","author":"Wang","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2016.11.037_bib0545","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/HYPERTENSIONAHA.107.089797","article-title":"Diastolic blood pressure and mortality in the elderly with cardiovascular disease","volume":"50","author":"Protogerou","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2016.11.037_bib0550","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/2012.jama.10503","article-title":"Aortic stiffness, blood pressure progression, and incident hypertension","volume":"308","author":"Kaess","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2016.11.037_bib0555","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/01.CIR.100.13.1387","article-title":"Association between local pulse pressure, mean blood pressure, and large-artery remodeling","volume":"100","author":"Boutouyrie","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.11.037_bib0560","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1097\/HJH.0000000000000969","volume":"34","author":"Stergiou","year":"2016","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2016.11.037_bib0565","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/CIRCULATIONAHA.116.022536","article-title":"The implications of blood pressure measurement methods on treatment targets for blood pressure","volume":"134","author":"Bakris","year":"2016","journal-title":"Circulation"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816305886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816305886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T02:54:50Z","timestamp":1657940090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816305886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":113,"alternative-id":["S1043661816305886"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.11.037","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should blood pressure goal be individualized in hypertensive patients?","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.11.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}